A Study of AS1411 Combined With Cytarabine in the Treatment of Patients With Primary Refractory or Relapsed Acute Myeloid Leukemia

NCT01034410 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: AS1411
DRUG: Cytarabine

Sponsor

Antisoma Research